期刊文献+

药物涂层球囊联合切割球囊行冠状动脉分叉病变边支保护的疗效观察 被引量:10

Efficacy of drug-coating balloon and cutting balloon angioplasty in side branch protection for coronary bifurcation lesions
下载PDF
导出
摘要 目的探索切割球囊联合药物球囊行冠状动脉分叉病变分支血管保护的即刻效果及远期预后。方法回顾性选取2017年1月至2018年6月解放军总医院收治的冠状动脉分叉病变患者60例为研究对象。依据治疗方法分为2组:研究组(n=28)和对照组(n=32)。研究组和对照组分别预埋药物球囊和普通球囊。比较2组患者基线资料、即刻手术效果、围手术期并发症,以及随访9个月发生的主要不良心血管事件(MACE)、靶病变血运重建和晚期管腔丢失(LLL)。采用SPSS24.0软件进行统计分析。依据数据类型,组间比较分别采用t检验或χ^2检验。结果2组患者术前病变类型及影像学参数、术后主支及分支血管最小直径和残余狭窄间差异无统计学意义(P>0.05)。2组患者围手术期均无并发症发生。研究组和对照组患者MACE发生率间差异具有统计学意义[25.8%(8/31)vs3.57%(1/28),P=0.044],但2组靶病变血运重建率[3.57%(1/28)vs9.88%(3/31),P>0.05]差异无统计学意义。部分患者术后9个月完成影像学复查,研究组和对照组主支直径及主支LLL差异无统计学意义(P>0.05),但分支血管最小直径[(2.50±0.48)vs(1.96±0.39)mm,P=0.013]及分支血管LLL[(0.04±0.07)vs(0.25±0.36)mm,P=0.024]间差异具有统计学意义(P<0.05)。结论切割球囊联合药物球囊在冠状动脉分叉病变分支保护中安全、有效。 Objective To evaluate the immediate and long-term effectiveness of applying cutting balloon angioplasty combined with drug-coating balloon (DCB) in side branch protection of coronary bifurcation lesions. Methods Sixty patients with coronary bifurcation lesions admitted in the Chinese PLA General Hospital from January 2017 to June 2018 were subjected in this study. They were divided into research group ( n =28) and control group ( n =32) according to use of DCB or ordinary balloon in the side breach after cutting balloon as pretreatment. Basic clinical data,instant effectiveness of operation,perioperative complications,and occurrences of major adverse cardiac events (MACE),target lesion revascularization (TLR) and late lumen loss (LLL) within 9 months after surgery were compared between the 2 groups. SPSS statistics 24.0 was used to perform the statistical analysis. Student′s t test or Chi-square test was employed for comparison between groups in different data types. Results There were no significant differences in lesion types,radiological parameters,postoperative stenosis and minimal lumen diameters (MLD) of main and side branches between 2 groups ( P >0.05). No perioperative complications was observed in both groups. The incidence of MACE within 9 months were significantly lower in the research group than in the control group [3.57%(1/28) vs 25.8%(8/31),P =0.044],but no difference was seen in the rate of TLR between them [3.57%(1/28) vs 9.88%(3/31),P >0.05]. Among the patients who underwent radiological examination in 9 months after surgery,there was no difference in the diameter and LLL of main branch between the 2 groups ( P >0.05 ),but statistical differences were seen in MLD [(2.50±0.48) vs (1.96±0.39)mm,P =0.013] and LLL [(0.04±0.07) vs (0.25±0.36)mm,P =0.024] of side branch. Conclusion DCB-combined cutting balloon angioplasty is effective and safe in side branch protection technique of coronary bifurcation lesions.
作者 张文龙 赵宇 白静 王禹 ZHANG Wen-Long;ZHAO Yu;BAI Jing;WANG Yu(Department of Cardiology,First Medical Center,Chinese PLA General Hospital,Beijing 100853,China)
出处 《中华老年多器官疾病杂志》 2019年第7期498-502,共5页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 冠状动脉疾病 药物涂层球囊 切割球囊 冠状动脉分叉病变边支保护 coronary artery disease drug-coating balloon cutting balloon side branch protection of coronary bifurcation lesions
  • 相关文献

参考文献7

二级参考文献72

  • 1王悦喜,季英敏,袁托亚,王春燕,阿荣,于赛华,刘晓宇,田子英,王呼萍,张剑,孟庆余.冠心病介入诊疗132例分析[J].内蒙古医学院学报,2004,26(4):270-272. 被引量:6
  • 2王悦喜,阿荣,袁托亚.冠心病合并糖尿病患者金属裸支架植入术的治疗效果及安全性评价[J].中国全科医学,2006,9(15):1235-1236. 被引量:13
  • 3王悦喜,袁托亚,阿荣,王春燕,季英敏,于赛华,刘晓宇,田子英,王呼萍,张剑,孟庆余.介入诊治冠心病患者339例[J].内蒙古医学杂志,2007,39(1):17-20. 被引量:3
  • 4[4]Leferve T,Louvard Y,Morice MC,et al.Stenting of bifuecation lesions:classification,treatment,and results.Catherter Cardiovasc Interv,2000,49:274-283.
  • 5[5]Hoye A,Iakovou I,Ge L,et al.Long term outcomes after stenting of bifurcation lesions with "crush" technique:predictors of an adverse outcome.J Am Coll Cardiol,2006,47:1949-1958.
  • 6[6]Steigen TK,Maeng M,Wiseth R,et al.Randomized study on simple versus complex stenting of coronary artery bifurcation lesions:the Nordic bifurcation study.Circulation,2006,114:1955-1961.
  • 7[7]Valgimigli M,Malagutti P,Rodriguez-Granillo GA,et al.Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era.Clinical and angiographic insights into the Rapamycin-eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (TSEARCH) registries.Am Heart J,2006,152:896-902.
  • 8[8]Herrmann HC.Prevention of cardiovascular events after pereutaneous coronary intervention.N Engl J Med,2004,350:2708-2710.
  • 9Mathey DG, Wendig I, Boxberger M, et al. Treatment of bifurcation lesions with a drug-eluting balloon: The PEPCAD V(Paclitaxel eluting PTCA balloon in coronary artery disease) trial [J]. EuroIntervention, 2011, 7(Suppl K): K61-K65.
  • 10Fanggiday JC, Stella PR, Guyomi SH, et al. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: The DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry [J]. Catheter Cardiovasc Interv, 2008, 71(5): 629-635.

共引文献227

同被引文献72

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部